Roche Holding AG Boosts Position in Diabetes Market with Buy; To Make Upfront Payment of $160 Million for Medingo

Reuters -- Roche Holding AG (ROG.VX) has bolstered its position in the diabetes market by buying Elron Electronics' (ELRN.TA) Medingo unit in a deal worth up to $200 million, the Swiss drugmaker said on Tuesday.
MORE ON THIS TOPIC